课题基金 / 基金详情

The first characterization of functional CYP450 activities in human cardiac myocytes: Modulation of cardiac potassium channel block due to the local metabolism of QT-prolonging drugs.

The first characterization of functional CYP450 activities in human cardiac myocytes: Modulation of cardiac potassium channel block due to the local metabolism of QT-prolonging drugs.
人类心肌细胞中功能性 CYP450 活性的首次表征:由于 QT 延长药物的局部代谢而调节心脏钾通道阻滞。
批准号:
238460
负责人:
Turgeon Jacques
金额:
$58.79万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2016-09-01

项目摘要

项目成果

Turgeon Jacques的其他基金

相似基金

相关文献

中文摘要
翻译
传统的药代动力学概念认为,肝脏和肠道中的酶(cyp450)是全身暴露于药物的关键决定因素。此外,组织中游离药物浓度也是一个需要考虑的重要因素
英文摘要
Conventional concepts in pharmacokinetics propose that enzymes (CYP450s) in the liver and intestines are key determinants of the systemic exposure to a drug. As well, it is known that the free drug concentration in tissues is an important factor to consid
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of novel pathogenic roles of CYP450s in breast cancer
海外基金